May 29, 2012

AVEO Oncology to Present at the Jefferies 2012 Global Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–May. 29, 2012– AVEO Oncology (Nasdaq: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 3:00 p.m. (ET) in New York City.

A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveooncology.com.

Source: AVEO Oncology

Investor Contact:
AVEO Oncology
Monique Allaire, 617-299-5810
or
Media Contact:
AVEO Oncology
Rob Kloppenburg, 617-930-5595

Press Release

AVEO Oncology to Present at the Jefferies 2012 Global Healthcare Conference

Click Here To View Our ASCO Poster:

TIVO-3: Final OS Analysis Of A Phase III, Randomized, Controlled, Multicenter, Open-Label Study To Compare Tivozanib To Sorafenib In Subjects With Metastatic Renal Cell Carcinoma (RCC)